Three models of two syringe brands were analyzed for the presence of SO: Saldanha-Rodrigues (SR) 1-mL insulin syringe (Saldanha-Rodrigues, Manaus, Brazil, lot #3719K); BD Plastipak 1-mL insulin ...

Becton, Dickinson and Company (BD) and Ypsomed have announced an expansion of their partnership with the development of a 5.5ml version of the BD Neopak XtraFlow glass prefillable syringe. The new ...

This partnership builds on the companies’ previous collaboration on the BD Neopak XtraFlow 2.25 mL Glass Prefillable Syringe and YpsoMate 2.25 autoinjector, which demonstrated improved flow across ...

Becton, Dickinson and Co. plans to invest more than $110 million to expand a prefilled flush syringe manufacturing facility in Nebraska. According to BD, the plan aims to better meet growing demand ...

Indiana Attorney General Todd Rokita on Monday announced a new lawsuit against Indianapolis-based drug maker Eli Lilly and Co. The attorney general contends this suit, as well as previous litigation ...

RICHMOND, Va. — Virginia’s attorney general has filed a lawsuit against pharmacy benefit managers and pharmaceutical manufacturers over insulin prices. Attorney General Jason Miyares filed the lawsuit ...

An Ontario trial judge was right to give the jury in a murder trial instructions that did not account for the possibility that the accused, a nurse, had supplied insulin to one of her alleged victims ...

CHEONGJU, South Korea--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a ...

Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...